PROTAC 工程化蛋白/DNA 纳米抗原是癌症免疫治疗中树突状细胞疫苗的有效增强剂
PROTAC-Engineered Protein/DNA Nanoantigen is a Potent Booster for Dendritic Cell Vaccines in Cancer Immunotherapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells.
Pan-Cancer Analyses Refine the Single-Cell Portrait of Tumor-Infiltrating Dendritic Cells.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
树突状细胞(DC)是抗肿瘤免疫的关键协调者。基于DC的抗肿瘤治疗正在积极开发中,但尚未取得有效的临床应答。进一步探索肿瘤微环境中及跨癌种间DC的异质性,可能为开发基于DC的免疫治疗提供见解。在本研究中,我们整合了来自33种癌症类型、超过2,500个样本的DC单细胞RNA测序数据,建立了人类DC的综合蓝图。几种罕见的DC亚群浸润肿瘤,包括AXL+SIGLEC6+ DC和朗格汉斯细胞样DC,并展现出以独特转录组特征为标志的功能潜力。计算分析表明,朗格汉斯细胞样亚群可能是肿瘤富集LAMP3+ DC的额外细胞来源,且不同的细胞来源与LAMP3+ DC的多效性功能潜力相关。此外,该DC图谱使得能够开发一个机器学习模型,用于指导后续单细胞分析中的DC注释,并优先筛选出增强抗肿瘤DC疫苗的有价值靶点。这一整合性资源为揭示肿瘤浸润DC的复杂性提供了全景视角,并为开发靶向DC的疗法提供了宝贵见解。意义:对肿瘤浸润树突状细胞的全面剖析重新定义了具有不同调控、组织偏好和功能潜力的细胞亚群,并提供了一个具有广阔应用前景的丰富资源图谱。本文是特别系列“以计算研究、数据科学和机器学习/人工智能推动癌症发现”的一部分。
UNLABELLED: Dendritic cells (DC) are pivotal orchestrators of antitumor immunity. DC-based antitumor treatments are being actively developed, but effective clinical responses have not yet been achieved.
Further exploration of DC heterogeneity in the tumor microenvironment and across cancer types could provide insights for developing DC-based immunotherapies. In this study, we integrated single-cell RNA sequencing data of DCs from more than 2,500 samples across 33 cancer types and established a comprehensive blueprint of human DCs.
Several rare subsets of DCs infiltrated the tumors, including AXL+SIGLEC6+ DCs and Langerhans cell-like DCs, and displayed functional potentials marked with distinct transcriptomic characteristics. Computational analyses demonstrated that the Langerhans cell-like subset could be an additional cellular origin of tumor-enriched LAMP3+ DCs and that distinct cellular origins are associated with the pleiotropic functional potentials of LAMP3+ DCs.
Furthermore, this DC atlas enabled the development of a machine learning model to guide DC annotation for subsequent single-cell analysis and prioritization of a valuable target for enhancing antitumor DC vaccination. This integrative resource provides a panoramic view to unravel the complexity of tumor-infiltrating DCs and offers valuable insights for developing therapies targeting DCs.
SIGNIFICANCE: The comprehensive dissection of tumor-infiltrating dendritic cells redefined cell subsets with different regulations, tissue preferences, and functional potentials and provided an atlas as a rich resource with promising applications. This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。